The R&D center of the company was established in 2003, and in recent years, the company has been strengthening the infrastructure of the R&D center and the conditions of the R&D equipments. At present, the R&D center is set up as R&D laboratory, instrument room, chromatography room, central laboratory and office, etc. It covers an area of more than 1000 square meters. It covers an area of more than 1000 square meters. The company has a number of high-efficiency gas chromatograph, high-efficiency liquid chromatograph, ultraviolet spectrophotometer, mass spectrometer analyzer and other large-scale precision imported experimental instruments, with animal laboratories in line with national requirements. The company is also equipped with a full set of raw material synthesis and preparation production equipment and first-class testing and analyzing and testing equipment.
When the company was founded in 1999, the core technical personnel of the company cooperated with scientific research institutes at home and abroad to extract and purify bioactive substances from natural biotoxins by immuno (antibody variable region) affinity chromatography. After more than ten years of efforts, we have gradually formed the immuno (antibody variable region) affinity chromatography technology platform. With the help of this technology platform, we have successfully developed 6 natural protein peptide drugs with broad market prospects, and many of them have been put on the market with good clinical effects. The company mainly devotes itself to the research of biotoxin active substances, forming specialties and exploring their application and development in cardiovascular and cerebrovascular fields; it further improves the construction of immunity (antibody fragment) affinity chromatography technology platform, strengthens product innovation, improves the speed of product research and development, and forms the core competitiveness with patented and exclusive technologies.
The R&D Center has extensively absorbed high-level scientific and technological talents from home and abroad, and has built up a multidisciplinary and multilevel team of matching professional talents. By the end of 2011, the R&D center*** had 66 researchers, including 17 full-time researchers with doctorate, master's degree and undergraduate degree, 29 technicians and 20 research assistants. The product research and development department also has a number of experts to participate in the technical committee, mainly from the clinical medicine, pharmacy education and research and pharmaceutical experts more than ten people, for the product research and development department of the development strategy, project evaluation, decision-making to provide technical support. 2012 the company was approved to establish the development zone of the postdoctoral workstation scientific research sub-station, and has begun the postdoctoral scientific research work.